These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32832238)

  • 1. Factors Influencing Retinal Pigment Epithelium-Atrophy Progression Rate in Stargardt Disease.
    Cicinelli MV; Rabiolo A; Brambati M; Viganò C; Bandello F; Battaglia Parodi M
    Transl Vis Sci Technol; 2020 Jun; 9(7):33. PubMed ID: 32832238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal Pigment Epithelium Atrophy in Recessive Stargardt Disease as Measured by Short-Wavelength and Near-Infrared Autofluorescence.
    Jauregui R; Nuzbrokh Y; Su PY; Zernant J; Allikmets R; Tsang SH; Sparrow JR
    Transl Vis Sci Technol; 2021 Jan; 10(1):3. PubMed ID: 33505770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease.
    Lindner M; Lambertus S; Mauschitz MM; Bax NM; Kersten E; Lüning A; Nadal J; Schmitz-Valckenberg S; Schmid M; Holz FG; Hoyng CB; Fleckenstein M;
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1001-1007. PubMed ID: 28288486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundus autofluorescence and microperimetry in progressing geographic atrophy secondary to age-related macular degeneration.
    Pilotto E; Guidolin F; Convento E; Spedicato L; Vujosevic S; Cavarzeran F; Midena E
    Br J Ophthalmol; 2013 May; 97(5):622-6. PubMed ID: 23410728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations among near-infrared and short-wavelength autofluorescence and spectral-domain optical coherence tomography in recessive Stargardt disease.
    Duncker T; Marsiglia M; Lee W; Zernant J; Tsang SH; Allikmets R; Greenstein VC; Sparrow JR
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):8134-43. PubMed ID: 25342616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecks in Recessive Stargardt Disease: Short-Wavelength Autofluorescence, Near-Infrared Autofluorescence, and Optical Coherence Tomography.
    Sparrow JR; Marsiglia M; Allikmets R; Tsang S; Lee W; Duncker T; Zernant J
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):5029-39. PubMed ID: 26230768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric Inter-Eye Progression in Stargardt Disease.
    Lambertus S; Bax NM; Groenewoud JM; Cremers FP; van der Wilt GJ; Klevering BJ; Theelen T; Hoyng CB
    Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6824-6830. PubMed ID: 28002570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morpho-functional correlation of fundus autofluorescence in Stargardt disease.
    Parodi MB; Iacono P; Triolo G; La Spina C; Zucchiatti I; Cicinelli MV; Borrelli E; Manitto MP; Martina E; Bandello F
    Br J Ophthalmol; 2015 Oct; 99(10):1354-9. PubMed ID: 25837607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
    Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence in Stargardt Disease.
    Greenstein VC; Nunez J; Lee W; Schuerch K; Fortune B; Tsang SH; Allikmets R; Sparrow JR; Hood DC
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5227-5236. PubMed ID: 29049723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
    Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
    JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
    Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct characteristics of inferonasal fundus autofluorescence patterns in stargardt disease and retinitis pigmentosa.
    Duncker T; Lee W; Tsang SH; Greenberg JP; Zernant J; Allikmets R; Sparrow JR
    Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6820-6. PubMed ID: 24071957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared autofluorescence in young choroideremia patients.
    Mucciolo DP; Murro V; Giorgio D; Sodi A; Passerini I; Virgili G; Rizzo S
    Ophthalmic Genet; 2019 Oct; 40(5):421-427. PubMed ID: 31544579
    [No Abstract]   [Full Text] [Related]  

  • 15. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
    Sisk RA; Leng T
    Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of Late-Onset Stargardt Type 1 Disease: Characteristics, Genetics, and Progression.
    Li CHZ; Pas JAAH; Corradi Z; Hitti-Malin RJ; Hoogstede A; Runhart EH; Dhooge PPA; Collin RWJ; Cremers FPM; Hoyng CB
    Ophthalmology; 2024 Jan; 131(1):87-97. PubMed ID: 37598860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stages of Drusen-Associated Atrophy in Age-Related Macular Degeneration Visible via Histologically Validated Fundus Autofluorescence.
    Chen L; Messinger JD; Ferrara D; Freund KB; Curcio CA
    Ophthalmol Retina; 2021 Aug; 5(8):730-742. PubMed ID: 33217617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset stargardt disease: phenotypic and genotypic characteristics.
    Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
    Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.
    Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Mackey DA; Constable IJ; De Roach JN; Chen FK
    Ophthalmol Sci; 2021 Mar; 1(1):100005. PubMed ID: 36246008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of multimodal imaging in the various stages of Stargardt disease].
    El Matri L; Falfoul Y; Kortli M; Hassairi A; Charfi H; Turki A; Kort F; Chebil A
    J Fr Ophtalmol; 2017 Oct; 40(8):666-675. PubMed ID: 28919188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.